Epigenomics AG Stock Xetra
Equities
DE000A1K0516
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.44M 1.57M 2.13M |
---|---|---|---|---|---|
Net income 2024 * | - 0 0 | Net income 2025 * | - 0 0 | EV / Sales 2024 * | - |
Net cash position 2024 * | 2.48M 2.69M 3.66M | Net cash position 2025 * | 1.39M 1.5M 2.05M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.84
x | P/E ratio 2025 * |
-2.87
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.77% |
Managers | Title | Age | Since |
---|---|---|---|
Frederic Hilke
IRC | Investor Relations Contact | - | - |
Annett Dietrich
HRO | Human Resources Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Helge Lubenow
CHM | Chairman | 56 | 16-05-24 |
Jochen Hummel
BRD | Director/Board Member | 54 | 02-04 |
Alexander Link
BRD | Director/Board Member | 53 | 20-05-31 |
1st Jan change | Capi. | |
---|---|---|
-27.01% | 9.96B | |
-8.58% | 3.03B | |
+31.86% | 3B | |
-13.62% | 2.18B | |
-16.32% | 1.76B | |
+63.36% | 1.42B | |
+27.00% | 794M | |
-2.18% | 756M | |
+3.18% | 305M |